Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2023-09-27 00:00:00 ET · period of report 2023-09-26 · accession 0001104659-23-104099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-27 | 2023-09-26 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $0.28 | +100.0K | 15.45M | +0.7% | +$28.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK, PAR VALUE $0.001 | 2023-09-26 | P | A | 100,000 | $0.28 | 15,449,091 | D | — | — |